 Curtis VandenBerg
Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anterior Cruciate Ligament Injuries | 8 | 2023 | 147 | 2.550 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 9 | 2023 | 143 | 2.210 |
Why?
| | Femoral Fractures | 2 | 2022 | 65 | 1.450 |
Why?
| | Hip Joint | 2 | 2019 | 144 | 1.150 |
Why?
| | Bone Cysts | 1 | 2022 | 10 | 0.850 |
Why?
| | Fractures, Spontaneous | 1 | 2022 | 14 | 0.850 |
Why?
| | Hamstring Tendons | 1 | 2021 | 15 | 0.800 |
Why?
| | Fracture Fixation, Internal | 2 | 2022 | 187 | 0.790 |
Why?
| | Closed Fracture Reduction | 1 | 2019 | 7 | 0.720 |
Why?
| | Bone Neoplasms | 1 | 2022 | 198 | 0.710 |
Why?
| | Therapeutic Irrigation | 1 | 2019 | 67 | 0.700 |
Why?
| | Debridement | 1 | 2019 | 79 | 0.690 |
Why?
| | Fracture Fixation, Intramedullary | 2 | 2020 | 53 | 0.680 |
Why?
| | Arthritis, Infectious | 1 | 2019 | 52 | 0.670 |
Why?
| | Fractures, Closed | 1 | 2019 | 15 | 0.670 |
Why?
| | Tibial Fractures | 1 | 2019 | 70 | 0.660 |
Why?
| | Clinical Protocols | 2 | 2020 | 234 | 0.620 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 100 | 0.600 |
Why?
| | Spine | 1 | 2018 | 144 | 0.570 |
Why?
| | Femoracetabular Impingement | 1 | 2016 | 50 | 0.550 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 251 | 0.530 |
Why?
| | Pubic Bone | 1 | 2014 | 4 | 0.510 |
Why?
| | Patient Compliance | 1 | 2018 | 532 | 0.480 |
Why?
| | Knee Joint | 5 | 2023 | 353 | 0.440 |
Why?
| | Lower Extremity | 4 | 2023 | 334 | 0.420 |
Why?
| | Anterior Cruciate Ligament | 3 | 2023 | 89 | 0.420 |
Why?
| | Child | 16 | 2023 | 19033 | 0.420 |
Why?
| | Retrospective Studies | 13 | 2022 | 12932 | 0.410 |
Why?
| | Range of Motion, Articular | 5 | 2021 | 369 | 0.400 |
Why?
| | Biomechanical Phenomena | 5 | 2021 | 683 | 0.390 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1197 | 0.390 |
Why?
| | Patellar Ligament | 2 | 2022 | 26 | 0.380 |
Why?
| | Tendons | 3 | 2022 | 136 | 0.380 |
Why?
| | Athletes | 4 | 2023 | 342 | 0.350 |
Why?
| | Tibial Meniscus Injuries | 2 | 2019 | 46 | 0.340 |
Why?
| | Adolescent | 15 | 2023 | 18364 | 0.330 |
Why?
| | Menisci, Tibial | 2 | 2019 | 59 | 0.330 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1514 | 0.330 |
Why?
| | Reoperation | 2 | 2022 | 557 | 0.320 |
Why?
| | Exercise Test | 3 | 2020 | 552 | 0.300 |
Why?
| | Female | 20 | 2023 | 61268 | 0.290 |
Why?
| | Orthopedic Procedures | 2 | 2018 | 225 | 0.260 |
Why?
| | Return to Sport | 3 | 2023 | 85 | 0.250 |
Why?
| | Length of Stay | 2 | 2019 | 1027 | 0.250 |
Why?
| | Child, Preschool | 5 | 2022 | 9448 | 0.250 |
Why?
| | Male | 17 | 2023 | 57479 | 0.240 |
Why?
| | Databases, Factual | 2 | 2019 | 1196 | 0.240 |
Why?
| | Autografts | 2 | 2021 | 49 | 0.240 |
Why?
| | Movement | 3 | 2021 | 248 | 0.230 |
Why?
| | Humans | 24 | 2023 | 118268 | 0.230 |
Why?
| | Cartilage, Articular | 2 | 2019 | 306 | 0.230 |
Why?
| | Patellofemoral Joint | 1 | 2022 | 9 | 0.220 |
Why?
| | United States | 4 | 2019 | 12496 | 0.220 |
Why?
| | Knee Injuries | 2 | 2019 | 103 | 0.190 |
Why?
| | Femur | 1 | 2022 | 199 | 0.190 |
Why?
| | Salter-Harris Fractures | 1 | 2020 | 10 | 0.190 |
Why?
| | Rotation | 2 | 2021 | 121 | 0.190 |
Why?
| | Humeral Fractures | 1 | 2020 | 47 | 0.180 |
Why?
| | Data Collection | 2 | 2019 | 652 | 0.180 |
Why?
| | Ankle Injuries | 1 | 2020 | 74 | 0.170 |
Why?
| | Conversion Disorder | 1 | 2019 | 10 | 0.170 |
Why?
| | Casts, Surgical | 1 | 2019 | 31 | 0.170 |
Why?
| | Bone Nails | 1 | 2019 | 60 | 0.160 |
Why?
| | Hospitals, Teaching | 1 | 2019 | 104 | 0.160 |
Why?
| | Treatment Outcome | 3 | 2022 | 9319 | 0.160 |
Why?
| | Upper Extremity | 1 | 2019 | 81 | 0.160 |
Why?
| | Shoulder Dislocation | 1 | 2019 | 55 | 0.160 |
Why?
| | Hospital Costs | 1 | 2019 | 110 | 0.160 |
Why?
| | Insurance Coverage | 1 | 2019 | 208 | 0.160 |
Why?
| | Time-to-Treatment | 1 | 2019 | 148 | 0.160 |
Why?
| | Sports | 1 | 2020 | 191 | 0.150 |
Why?
| | Blood Coagulation Disorders | 1 | 2019 | 166 | 0.150 |
Why?
| | Social Class | 1 | 2019 | 217 | 0.150 |
Why?
| | Risk Management | 1 | 2018 | 90 | 0.150 |
Why?
| | Magnetic Resonance Imaging | 2 | 2019 | 3169 | 0.140 |
Why?
| | Postoperative Complications | 3 | 2020 | 2230 | 0.140 |
Why?
| | Inpatients | 1 | 2019 | 387 | 0.140 |
Why?
| | Risk Factors | 3 | 2018 | 8958 | 0.130 |
Why?
| | Interleukin-1alpha | 1 | 2015 | 56 | 0.130 |
Why?
| | Odds Ratio | 1 | 2018 | 993 | 0.130 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2014 | 20 | 0.130 |
Why?
| | Tissue Engineering | 2 | 2015 | 363 | 0.120 |
Why?
| | Comorbidity | 1 | 2019 | 1516 | 0.120 |
Why?
| | Chondrogenesis | 1 | 2014 | 80 | 0.120 |
Why?
| | Athletic Injuries | 1 | 2020 | 476 | 0.120 |
Why?
| | Cytokines | 2 | 2015 | 1880 | 0.110 |
Why?
| | Chondrocytes | 1 | 2015 | 206 | 0.110 |
Why?
| | Case-Control Studies | 2 | 2018 | 3156 | 0.110 |
Why?
| | Young Adult | 2 | 2019 | 10731 | 0.110 |
Why?
| | Pelvic Bones | 1 | 2014 | 125 | 0.110 |
Why?
| | Incidence | 1 | 2018 | 2413 | 0.100 |
Why?
| | Infant | 2 | 2022 | 8254 | 0.100 |
Why?
| | Hospitalization | 1 | 2019 | 1778 | 0.090 |
Why?
| | Prospective Studies | 3 | 2020 | 6443 | 0.090 |
Why?
| | Quality Improvement | 1 | 2018 | 962 | 0.090 |
Why?
| | Plyometric Exercise | 2 | 2018 | 4 | 0.080 |
Why?
| | Laryngectomy | 1 | 2007 | 19 | 0.080 |
Why?
| | Salvage Therapy | 1 | 2007 | 130 | 0.070 |
Why?
| | Surgical Flaps | 1 | 2007 | 118 | 0.070 |
Why?
| | Kinetics | 2 | 2020 | 1623 | 0.070 |
Why?
| | Molybdenum | 1 | 2005 | 9 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2433 | 0.060 |
Why?
| | Tumor Burden | 1 | 2005 | 275 | 0.060 |
Why?
| | Angiogenesis Inhibitors | 1 | 2005 | 218 | 0.060 |
Why?
| | Patella | 1 | 2022 | 25 | 0.050 |
Why?
| | Cattle | 2 | 2015 | 974 | 0.050 |
Why?
| | Ligaments, Articular | 1 | 2022 | 52 | 0.050 |
Why?
| | Cohort Studies | 2 | 2023 | 5078 | 0.050 |
Why?
| | Cadaver | 1 | 2022 | 327 | 0.050 |
Why?
| | Pain, Postoperative | 1 | 2023 | 210 | 0.050 |
Why?
| | Humerus | 1 | 2020 | 44 | 0.050 |
Why?
| | Open Fracture Reduction | 1 | 2020 | 26 | 0.050 |
Why?
| | Pain Management | 1 | 2023 | 293 | 0.040 |
Why?
| | Los Angeles | 1 | 2019 | 55 | 0.040 |
Why?
| | Head and Neck Neoplasms | 1 | 2005 | 469 | 0.040 |
Why?
| | Lacerations | 1 | 2019 | 30 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2005 | 610 | 0.040 |
Why?
| | Rupture | 1 | 2019 | 105 | 0.040 |
Why?
| | Posture | 1 | 2020 | 158 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2019 | 1787 | 0.040 |
Why?
| | Bone Screws | 1 | 2020 | 125 | 0.040 |
Why?
| | Time and Motion Studies | 1 | 2018 | 23 | 0.040 |
Why?
| | Hip | 1 | 2018 | 46 | 0.040 |
Why?
| | Knee | 1 | 2018 | 52 | 0.040 |
Why?
| | Ankle | 1 | 2018 | 71 | 0.040 |
Why?
| | Patients | 1 | 2019 | 174 | 0.040 |
Why?
| | Arthroscopy | 1 | 2019 | 234 | 0.040 |
Why?
| | Pain | 1 | 2023 | 736 | 0.040 |
Why?
| | Joint Instability | 1 | 2019 | 171 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2015 | 4044 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2018 | 164 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 2355 | 0.040 |
Why?
| | Child Health Services | 1 | 2019 | 177 | 0.040 |
Why?
| | Pain Measurement | 1 | 2019 | 468 | 0.040 |
Why?
| | Cell Movement | 2 | 2014 | 888 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 971 | 0.030 |
Why?
| | Physical Therapy Modalities | 1 | 2018 | 274 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2023 | 789 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 504 | 0.030 |
Why?
| | Adult | 1 | 2016 | 31327 | 0.030 |
Why?
| | Dogs | 1 | 2015 | 369 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2018 | 4575 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1379 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2014 | 268 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2321 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4523 | 0.030 |
Why?
| | Algorithms | 1 | 2019 | 1522 | 0.030 |
Why?
| | Disease Models, Animal | 2 | 2015 | 3676 | 0.030 |
Why?
| | Cutaneous Fistula | 1 | 2007 | 13 | 0.020 |
Why?
| | Pharyngeal Diseases | 1 | 2007 | 14 | 0.020 |
Why?
| | Fistula | 1 | 2007 | 27 | 0.020 |
Why?
| | Deglutition | 1 | 2007 | 62 | 0.020 |
Why?
| | Laryngeal Neoplasms | 1 | 2007 | 39 | 0.020 |
Why?
| | Middle Aged | 2 | 2023 | 27514 | 0.020 |
Why?
| | Animals | 3 | 2015 | 33152 | 0.020 |
Why?
| | Constriction, Pathologic | 1 | 2007 | 204 | 0.020 |
Why?
| | Speech | 1 | 2007 | 75 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2005 | 188 | 0.020 |
Why?
| | Mice, SCID | 1 | 2005 | 331 | 0.020 |
Why?
| | Probability | 1 | 2005 | 302 | 0.020 |
Why?
| | Species Specificity | 1 | 2005 | 559 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2005 | 871 | 0.010 |
Why?
| | Neovascularization, Pathologic | 1 | 2005 | 286 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1082 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 817 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2005 | 1681 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2005 | 717 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2005 | 2434 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2005 | 1056 | 0.010 |
Why?
| | Rats | 1 | 2005 | 5339 | 0.010 |
Why?
| | Risk Assessment | 1 | 2005 | 3043 | 0.010 |
Why?
| | Mice | 1 | 2005 | 15446 | 0.010 |
Why?
|
|
VandenBerg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|